News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
41,856 Results
Type
Article (2720)
Company Profile (28)
Press Release (39107)
Multimedia
Podcasts (17)
Webinars (2)
Section
Business (16013)
Career Advice (78)
Deals (2153)
Drug Delivery (12)
Drug Development (4214)
Employer Resources (10)
FDA (458)
Job Trends (791)
News (20408)
Policy (1057)
Tag
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Standard (1)
2027 Genetown Digital (1)
2027 NextGen (2)
2027 Pharm Country Digital (1)
Academia (146)
ADA (4)
Allergies (8)
Alliances (3484)
ALS (10)
Alzheimer's disease (79)
Antibody-drug conjugate (ADC) (62)
Approvals (475)
Artificial intelligence (62)
ASCO (16)
Autoimmune disease (43)
Automation (6)
Bankruptcy (13)
Belgium (1)
Best Places to Work (477)
BIO (12)
Biologics (2)
BIOSECURE Act (2)
Biosimilars (27)
BioSpace Insights (13)
Biotechnology (17)
Bispecific (3)
Bladder cancer (11)
Brain cancer (9)
Breast cancer (64)
Cancer (506)
Cardiovascular disease (18)
Career advice (68)
Career pathing (1)
CAR-T (55)
CDC (3)
CDMO (10)
Celiac Disease (1)
Cell therapy (120)
Cervical cancer (9)
Clinical research (3713)
Collaboration (283)
Commercialization (3)
Company closure (4)
Compensation (161)
Complete response letters (1)
COVID-19 (189)
CRISPR (16)
CRO (1)
C-suite (214)
Cystic fibrosis (8)
Data (705)
Denatured (6)
Depression (12)
Dermatology (2)
Diabetes (25)
Diagnostics (519)
Digital health (2)
Diversity (2)
Diversity, equity & inclusion (1)
Drug discovery (63)
Drug pricing (10)
Duchenne muscular dystrophy (66)
Earnings (4782)
Editorial (7)
Employer branding (1)
Employer resources (8)
ESMO (27)
Events (6769)
Executive appointments (172)
FDA (680)
Fragile X (1)
Friedreich's ataxia (9)
Frontotemporal dementia (1)
Funding (254)
Gene editing (47)
Generative AI (3)
Gene therapy (87)
GLP-1 (83)
Government (170)
Guidances (25)
Healthcare (731)
Hematology (8)
HIV (4)
Huntington's disease (6)
IgA nephropathy (18)
Immunology and inflammation (45)
Immuno-oncology (27)
Indications (12)
Infectious disease (215)
Inflammatory bowel disease (15)
Inflation Reduction Act (6)
Influenza (9)
Intellectual property (45)
Interviews (7)
IPO (1007)
IRA (7)
Job creations (291)
Job search strategy (62)
JPM (5)
Kidney cancer (15)
Kidney disease (9)
Labor market (13)
Layoffs (57)
Leadership (4)
Legal (213)
Licensing (9)
Liver cancer (8)
Longevity (7)
Lung cancer (49)
Lung diease (3)
Lymphoma (21)
Machine learning (5)
Management (4)
Manufacturing (99)
MASH (19)
Medical device (318)
Medtech (323)
Mergers & acquisitions (1286)
Metabolic disorders (109)
mRNA (21)
Multiple sclerosis (30)
Multispecific (1)
Netherlands (1)
Neurodegenerative disease (46)
Neuropsychiatric disorders (14)
Neuroscience (235)
NextGen: Class of 2026 (355)
Non-profit (159)
Now hiring (18)
Obesity (54)
Opinion (21)
Ovarian cancer (34)
Pain (43)
Pancreatic cancer (29)
Parkinson's disease (17)
Partnered (4)
Patents (78)
Patient recruitment (66)
Patient selection (9)
Peanut (1)
People (6124)
Pharmaceutical (2)
Phase 1 (1584)
Phase 2 (1821)
Phase 3 (990)
Pipeline (971)
Policy (20)
Postmarket research (30)
Preclinical (679)
Press Release (3)
Prostate cancer (10)
Psychedelics (5)
Radioligand (1)
Radiopharmaceuticals (23)
Rare diseases (116)
Real estate (425)
Recruiting (5)
Regenerative medicine (1)
Regulatory (1033)
Reports (7)
Research institute (149)
Resumes & cover letters (9)
Rett syndrome (5)
RNA editing (7)
RSV (3)
Schizophrenia (18)
Series A (63)
Series B (30)
Sickle cell disease (3)
Special edition (3)
Spinal muscular atrophy (3)
Sponsored (1)
Startups (506)
Stomach cancer (4)
Supply chain (6)
Tariffs (2)
The Weekly (11)
Vaccines (82)
Venture capital (23)
Weight loss (30)
Women's health (31)
Women in leadership (1)
Worklife (2)
Date
Today (14)
Last 7 days (66)
Last 30 days (238)
Last 365 days (2464)
2026 (2039)
2025 (2445)
2024 (2592)
2023 (2857)
2022 (3752)
2021 (4041)
2020 (3464)
2019 (2059)
2018 (1549)
2017 (1795)
2016 (1620)
2015 (1833)
2014 (1367)
2013 (1188)
2012 (1392)
2011 (1334)
2010 (1178)
Location
Africa (43)
Alabama (3)
Arizona (21)
Asia (2050)
Australia (314)
California (2277)
Canada (354)
China (138)
Colorado (82)
Connecticut (24)
Delaware (19)
Europe (4183)
Florida (82)
Georgia (19)
Hawaii (2)
Idaho (3)
Illinois (35)
India (7)
Indiana (79)
Japan (26)
Kansas (16)
Kentucky (1)
Louisiana (2)
Maryland (85)
Massachusetts (841)
Michigan (15)
Minnesota (35)
Mississippi (1)
Missouri (6)
Nebraska (1)
Nevada (3)
New Hampshire (4)
New Jersey (190)
New York (128)
North Carolina (172)
Northern California (1182)
Ohio (66)
Oklahoma (3)
Oregon (7)
Pennsylvania (159)
Puerto Rico (1)
Rhode Island (4)
South America (40)
South Carolina (3)
Southern California (923)
Tennessee (6)
Texas (221)
United States (4590)
Utah (7)
Virginia (17)
Washington D.C. (4)
Washington State (122)
West Virginia (1)
Wisconsin (23)
41,856 Results for "antiva biosciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Antiva Biosciences Presents Data from Phase 1b/2 Study of ABI-2280 for Treatment of Cervical High-Risk HPV Infection at SGO 2026
April 15, 2026
·
6 min read
Biotech Bay
Antiva Biosciences Announces Formation of Scientific and Development Advisory Board
Antiva Biosciences announced the formation of a scientific and development advisory board featuring distinguished thought leaders from both academia and industry with clinical expertise spanning the fields of women’s health and virology.
June 13, 2024
·
7 min read
Business
Antiva Biosciences Strengthens Leadership with Key New Appointments
Antiva Biosciences today announced several key new appointments designed to strengthen the company’s leadership as it continues to advance its lead development candidate, ABI-2280.
October 19, 2023
·
6 min read
Press Releases
Finance & Accounting for Bioscience West debuts in San Diego this December
Discover innovative financial strategies and expert guidance from leading bioscience finance executives at this first-ever West Coast forum.
September 18, 2026
·
1 min read
Press Releases
Swiss Bioscience and OrganTech sign MOU to explore strategic collaboration in hair regeneration in Europe
Swiss Bioscience selected as OrganTech’s preferred strategic partner in Europe for regulatory development, GMP manufacturing, clinical research, and potential commercialization of the conditioned medium technology.
September 23, 2026
·
1 min read
Mergers & acquisitions
Argenx deepens immuno expertise with $2.2B Forte Biosciences buy
The star of the takeover is Forte Biosciences’ investigational antibody therapy, FB102, which has shown early potential in vitiligo and celiac disease.
July 27, 2026
·
2 min read
·
Tristan Manalac
Biotech Bay
Antiva Biosciences Closes $53 Million Series E Equity Financing Led by MPM-BioImpact Capital and Names Kristine Ball President and CEO
Antiva Biosciences today announced the closing of a $53 million Series E equity financing.
April 27, 2023
·
6 min read
Press Releases
Slingshot Biosciences Announces Leadership Transition
Dr. Nimisha Srivastava Appointed Chief Executive Officer to Lead the Company into Its Next Chapter
September 25, 2026
·
1 min read
Press Releases
Aulos Bioscience’s Imneskibart With Avelumab Delivers Exceptional Progression-Free Survival in Checkpoint Inhibitor-Refractory Adenocarcinoma Non-Small Cell Lung Cancer
October 26, 2026
·
6 min read
Press Releases
Vergent Bioscience Appoints Paul Friel to Board of Directors
October 28, 2026
·
3 min read
1 of 4,186
Next
